R1	Has_temporal Arg1:T1 Arg2:T2	
*	OR T5 T6
R2	AND Arg1:T4 Arg2:T5	
R3	Has_temporal Arg1:T4 Arg2:T3	
R4	Has_mood Arg1:T8 Arg2:T9	
*	OR T13 T14
R5	Has_mood Arg1:T13 Arg2:T12	
R6	multi Arg1:T11 Arg2:T13	
R7	Has_qualifier Arg1:T10 Arg2:T11	
*	OR T16 T17
R8	Has_mood Arg1:T10 Arg2:T16	
R9	Subsumes Arg1:T8 Arg2:T10	
R10	Has_mood Arg1:T23 Arg2:T22	
*	OR T21 T23
R11	Has_temporal Arg1:T21 Arg2:T24	
R12	multi Arg1:T26 Arg2:T27	
R13	Has_temporal Arg1:T26 Arg2:T28	
R14	Has_temporal Arg1:T29 Arg2:T30	
*	OR T26 T29
R15	Has_value Arg1:T31 Arg2:T32	
R16	Has_value Arg1:T33 Arg2:T34	
*	OR T35 T36
R17	Has_value Arg1:T35 Arg2:T37	
T1	Drug 12 24	tetracycline
T2	Temporal 25 40	within 6 months
T3	Temporal 44 51	history
T4	Condition 55 71	adverse reaction
T5	Drug 75 86	minocycline
T6	Drug 98 110	tetracycline
T8	Procedure 135 150	lumbar puncture
T9	Mood 116 129	Enhanced risk
T10	Condition 186 206	cerebral mass lesion
T11	Qualifier 207 261	predisposing to brain herniation or bleeding diathesis
T12	Mood 207 222	predisposing to
T13	Condition 223 239	brain herniation
T14	Condition 243 261	bleeding diathesis
T16	Mood 162 172	documented
T17	Mood 176 185	suspected
T21	Condition 267 276	Pregnancy
T22	Mood 280 291	expectation
T23	Condition 295 304	pregnancy
T24	Temporal 305 321	during the study
T26	Condition 334 357	opportunistic infection
T27	Qualifier 334 347	opportunistic
T28	Temporal 327 333	Active
T29	Condition 368 388	neurological disease
T30	Temporal 361 367	active
T31	Measurement 425 434	ADC Stage
T32	Value 435 438	> 1
T33	Measurement 444 454	Hemoglobin
T34	Value 455 466	< 10 Gms/dL
T35	Measurement 472 475	BUN
T36	Measurement 479 487	creatine
T37	Value 488 511	above the normal limits
T39	Drug 570 581	minocycline
T40	Non-representable 545 581	reduce the metabolism of minocycline
T41	Non-representable 517 628	Taking other drugs known to reduce the metabolism of minocycline and thus increase the probability of toxicity.
